Haislip v. Owens-Corning ( 1996 )


Menu:
  • UNPUBLISHED
    UNITED STATES COURT OF APPEALS
    FOR THE FOURTH CIRCUIT
    VALJEAN E. HAISLIP, Executrix of the
    Estate of Cleo A. Elmore, deceased,
    Plaintiff-Appellee,
    and
    THELMA C. ELMORE,
    Plaintiff,
    v.
    OWENS-CORNING FIBERGLAS
    CORPORATION,
    Defendant-Appellant,
    and
    AC&S, INCORPORATED, a
    Pennsylvania Corporation; AMCHEM
    PRODUCTS, INCORPORATED;
    No. 95-1687
    ARMSTRONG WORLD INDUSTRIES,
    INCORPORATED, formerly known as
    Armstrong Cork Company;
    BABCOCK & WILCOX COMPANY, a
    Delaware Corporation; CAREY
    CANADA, INCORPORATED; THE
    CELOTEX CORPORATION, Individually
    and as Successor-in-Interest to
    Philip Carey Manufacturing
    Company, Philip Carey Corporation,
    Panacon Corporation, Glen Alden
    Corporation, Rapid American
    Corporation, Briggs Manufacturing
    Company and Smith and Kansler, a
    Delaware Corporation; COMBUSTION
    ENGINEERING, INCORPORATED, a
    Delaware Corporation;
    CROWN CORK & SEAL COMPANY,
    INCORPORATED, Successor to Mundet
    Cork Corporation, a New York
    Corporation; EAGLE-PICHER
    INDUSTRIES, INCORPORATED, an Ohio
    Corporation; FIBREBOARD
    CORPORATION, Pabco Industrial
    Products Division, a Delaware
    Corporation; FLEXITALLIC GASKET
    COMPANY, INCORPORATED, a
    Connecticut Corporation; FLINTKOTE
    COMPANY, a Massachusetts
    Corporation; GARLOCK,
    INCORPORATED, PRECISION SEAL
    DIVISION, an Ohio Corporation; JOHN
    CRANE-HOUDAILLE, INCORPORATED,
    formerly known as Crane Packing
    Company; NATIONAL GYPSUM
    COMPANY, a Delaware Corporation;
    OWENS-ILLINOIS, INCORPORATED, an
    Ohio Corporation; PITTSBURGH-
    CORNING CORPORATION, Individually
    and as Successor-in-Interest to
    Union Asbestos and Rubber
    Company (UNARCO), a
    Pennsylvania Corporation; UNION
    CARBIDE CORPORATION, a New York
    Corporation; W.R. GRACE &
    COMPANY, a Connecticut
    Corporation; KEENE CORPORATION;
    GAF CORPORATION,
    Defendants,
    v.
    MANVILLE CORPORATION ASBESTOS
    DISEASE COMPENSATION FUND,
    Third Party Defendant.
    2
    Appeal from the United States District Court
    for the Eastern District of North Carolina, at Raleigh.
    Terrence W. Boyle, District Judge.
    (CA-90-181-BO)
    Argued: April 5, 1996
    Decided: May 23, 1996
    Before RUSSELL and MOTZ, Circuit Judges, and LAY,
    Senior Circuit Judge of the United States Court of Appeals for the
    Eighth Circuit, sitting by designation.
    _________________________________________________________________
    Affirmed by unpublished per curiam opinion.
    _________________________________________________________________
    COUNSEL
    ARGUED: Rebecca Anne Womeldorf, GIBSON, DUNN & CRUT-
    CHER, Washington, D.C., for Appellant. John Alan Jones,
    MICHAELS & JONES LAW OFFICES, P.A., Raleigh, North Caro-
    lina, for Appellee. ON BRIEF: Larry L. Simms, GIBSON, DUNN
    & CRUTCHER, Washington, D.C., for Appellant.
    _________________________________________________________________
    Unpublished opinions are not binding precedent in this circuit. See
    Local Rule 36(c).
    _________________________________________________________________
    OPINION
    PER CURIAM:
    Owens Corning Fiberglas (OCF) appeals the jury's verdict award-
    ing Cleo Elmore's estate (the "estate") over $2.8 million in compensa-
    3
    tory damages upon its finding that Elmore's exposure to OCF's
    asbestos-containing pipe covering was a substantial contributing fac-
    tor to his development of mesothelioma and resulting death. OCF
    contends the verdict was not supported by substantial evidence and
    that the jury's damage award was excessive. Finding no reversible
    error, we affirm.
    I.
    Cleo Elmore was exposed to various asbestos-containing products
    during his thirty years of service in the United States Navy. His earli-
    est known exposure was in 1946, and his last in 1970. OCF manufac-
    tured an asbestos-containing product called "Kaylo" from 1958 to
    1972. Although Elmore, testifying by way of deposition before he
    died, was unable to specifically recall any exposure to OCF-Kaylo
    during his service with the Navy, William Leonard, a friend and co-
    worker did remember.
    Leonard testified for the estate at trial that he and Elmore were con-
    struction workers aboard the USS Raleigh from 1962 to 1964.
    According to Leonard, he and Elmore endured extensive exposure to
    dust from asbestos products during this time, particularly pipe cover-
    ing. Leonard testified that OCF-Kaylo pipe covering was used aboard
    the USS Raleigh. He described it as a white pipe covering that was
    used extensively on the ship throughout the time he and Elmore
    worked there.
    According to Leonard, he and Elmore were responsible for check-
    ing the piping systems aboard the USS Raleigh over a nine-month
    period. Because the pipe covering was being cut to fit the newly-
    installed pipes, Leonard recounted that asbestos dust covered him and
    Elmore each day, especially Elmore who spent more time in close
    contact with the piping systems. They worked under these conditions
    nine hours per day, five days per week. Leonard, who was familiar
    with Elmore's entire Navy career, stated that Elmore was exposed to
    more asbestos dust during those nine months than at any other time
    in his career. And, while there were other brands of asbestos-
    containing materials on board, Leonard testified that they generated
    "minuscule" amounts of asbestos dust compared to that from
    OCF-Kaylo pipe covering.
    4
    To further establish Elmore's exposure to OCF-Kaylo, the estate
    introduced evidence in the form of invoices demonstrating that ship-
    ments totalling 22 tons of OCF-Kaylo were delivered to the shipyard
    where the USS Raleigh was docked during the relevant period. The
    estate also offered expert medical testimony from two doctors. The
    doctors testified that exposure to OCF-Kaylo to the degree described
    by Leonard, would be a substantial contributing factor to Elmore's
    contraction of mesothelioma (a form of lung cancer) and subsequent
    death.
    The estate presented evidence of damages in the form of testimony
    concerning the extent of Elmore's pain and suffering before death, his
    life expectancy in the absence of contracting mesothelioma, and his
    wife's near total dependence on Elmore. OCF elected not to present
    any testimony. The jury awarded the estate over $2.8 million in com-
    pensatory damages. This appeal followed.
    II.
    We turn first to OCF's contention that the evidence was not suffi-
    cient to support the jury's verdict. We will not reverse a jury's verdict
    for insufficient evidence unless, after viewing the evidence in the
    light most favorable to the verdict, no reasonable juror could have
    returned a verdict for the non-moving party. Brinkley-Obu v. Hughes
    Training, Inc., 
    36 F.3d 336
    , 351 (4th Cir. 1994).
    To prevail on a product liability asbestos action under North Caro-
    lina law, the estate needed to establish that OCF-Kaylo was a substan-
    tial contributing factor to Elmore's contraction of mesothelioma. See
    Jones v. Owens-Corning Fiberglas Corp. and Amchem Products, Inc.,
    
    69 F.3d 712
    , 716 (4th Cir. 1995). "To support a reasonable inference
    of substantial causation from circumstantial evidence, there must be
    evidence of exposure to a specific product on a regular basis over
    some extended period of time in proximity to where the plaintiff actu-
    ally worked." Lohrmann v. Pittsburgh Corning Corp., 
    782 F.2d 1156
    ,
    1162-63 (4th Cir. 1986).
    We think it abundantly clear the estate satisfied its burden of proof.
    Leonard's testimony established that Elmore was exposed to heavy
    concentrations of asbestos dust from OCF-Kaylo over at least a nine-
    5
    month period. And, expert medical testimony confirmed that such
    exposure would be a substantial contributing factor to Elmore's con-
    traction of mesothelioma.
    According to OCF, however, this evidence is insufficient because
    the estate needed to produce more than Leonard's testimony linking
    Elmore to OCF-Kaylo. OCF contends Leonard's testimony was insuf-
    ficient because he was a family friend and, as such, was biased in
    favor of Elmore. Additionally, OCF notes that Leonard did not origi-
    nally remember that OCF-Kaylo was the primary asbestos-containing
    product aboard the USS Raleigh; rather, he only recalled it years later
    after seeing a picture of OCF-Kaylo, which was apparently shown to
    him by the estate's counsel. The prejudicial impact of Leonard's testi-
    mony was magnified, according to OCF, because the estate then
    bootstrapped expert medical testimony onto its case, using Leonard's
    questionable testimony as the basis to ask these experts hypotheticals
    concerning causation.
    Despite its protestations to the contrary, at the heart of OCF's argu-
    ment is a mere challenge to Leonard's credibility, which is not a
    proper subject for appellate review. Brinkley-Obu, 
    36 F.3d at 351
     (cit-
    ing Charleston Area Med. Ctr., Inc. v. Blue Cross and Blue Shield
    Mut. of Ohio, Inc., 
    6 F.3d 243
    , 247-48 (4th Cir. 1993)). The jury was
    fully informed of the nature of Leonard's relationship to Elmore and
    the circumstances surrounding his recollection of OCF-Kaylo as the
    primary asbestos-containing product aboard the USS Raleigh. It was
    within the sole province of the jury to accept or reject his testimony.
    In any event, invoices from this period corroborated Leonard's testi-
    mony in part by establishing that large shipments of OCF-Kaylo were
    delivered to the loading docks where the USS Raleigh was undergo-
    ing construction. A reasonable inference from this evidence, in con-
    junction with Leonard's testimony, is that some, if not all, of these
    shipments were destined for the USS Raleigh. Cf. Lohrmann, 
    782 F.2d at 1163
     (holding that invoice evidence, standing alone, was not
    sufficient to establish that a particular product was a substantial con-
    tributing factor where invoices showed only the purchase of asbestos-
    containing product, but not when or where the product was used).
    We find the estate's evidence sufficient to support the jury's ver-
    dict that OCF-Kaylo was a substantial contributing factor to Elmore's
    contraction of mesothelioma.
    6
    III.
    OCF also challenges as excessive the jury's award of over $2.8
    million in compensatory damages. Appellate courts will intervene to
    correct an excessive jury verdict "`only in the most extreme circum-
    stances, as where the verdict is not merely excessive but "monstrous,"
    . . . . In very few cases, however, where such a possibility was dis-
    cussed has this high hurdle been surmounted.'" Arnold v. Eastern Air
    Lines, Inc., 
    681 F.2d 186
    , 201 (4th Cir. 1982) (quoting Simmons v.
    Avisco, Local 713, Textile Workers Union of America , 
    350 F.2d 1012
    ,
    1020 (4th Cir. 1965)), cert. denied, 
    460 U.S. 1102
     (1983).
    OCF contends the jury's verdict in the instant case meets this stan-
    dard because the estate proved only about $42,000 in medical and
    funeral expenses and at most $500,000 in lost retirement benefits. We
    disagree. OCF's argument simply overlooks the other elements of
    damages permissible under North Carolina law and proved by the
    estate, such as Elmore's pain and suffering, and compensation to
    Elmore's wife for lost care, assistance, companionship and comfort.
    On these points, the estate presented evidence that Elmore was devas-
    tated when he learned he had contracted terminal cancer. He had
    retired from the Navy to care for his wife who was totally blind. The
    two did everything together; he helped her garden and fish; he cooked
    meals for her and travelled around the country with her.
    After Elmore became severely ill, he had lung surgery which left
    him with a hole in his chest that spewed fluid when he coughed, and
    he had chemotherapy that left him physically frail. Elmore took mor-
    phine for severe pain. He was distraught and cried often. In his final
    days he asked to be taken off life support. Through all of this, his pri-
    mary concern was the care of his wife who was almost completely
    dependent on him. We certainly cannot say that the jury's award was
    "monstrous" in light of this evidence.
    IV.
    We, accordingly, affirm the jury's verdict in all respects.
    AFFIRMED
    7